Hostname: page-component-89b8bd64d-7zcd7 Total loading time: 0 Render date: 2026-05-12T08:31:13.621Z Has data issue: false hasContentIssue false

Oral administration of the milk casein-derived tripeptide Val-Pro-Pro attenuates high-fat diet-induced adipose tissue inflammation in mice

Published online by Cambridge University Press:  28 May 2014

Kotaro Aihara
Affiliation:
Department of Life Science and Bioethics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, M&D Tower S954, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan R&D Center, Calpis Company Limited, 5-11-10 Fuchinobe, Chuo-ku, Sagamihara-shi, Kanagawa 252-0206, Japan
Mizuko Osaka
Affiliation:
Department of Life Science and Bioethics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, M&D Tower S954, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
Masayuki Yoshida*
Affiliation:
Department of Life Science and Bioethics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, M&D Tower S954, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
*
* Corresponding author: Dr M. Yoshida, fax +81 3 5800 3380, email masavasc@tmd.ac.jp
Rights & Permissions [Opens in a new window]

Abstract

Inflammation of adipose tissue triggers the metabolic syndrome, atherosclerosis and CHD. In the present study, we investigated whether the milk casein-derived tripeptide valine-proline-proline (VPP) has an anti-inflammatory effect on the adipose tissue of high-fat diet (HFD)-fed mice. Male C57BL/6J mice (7 weeks of age) were fed ad libitum with either a HFD and plain tap water (HFD group) or a HFD and water containing 0·3 mg VPP/ml (HFD+VPP group) for 10 weeks. The results showed that the expression level of CD18 in the peripheral blood monocytes of the HFD+VPP group was significantly decreased compared with the level observed in those of the HFD group. Activated monocytes and pro-inflammatory macrophages were accumulated in the stromal vascular fractions of the adipose tissue from HFD-fed mice, which were significantly decreased in those supplemented with VPP. The formation of crown-like structures rich in pro-inflammatory macrophages was also significantly reduced in the adipose tissue of mice administered with VPP. Real-time PCR analysis revealed that the expression of monocyte chemoattractant protein-1 and that of the pro-inflammatory cytokine IL-6 in adipose tissue tend to be lower in the HFD+VPP group than in the HFD group. These observations indicate that oral administration of VPP exerts an anti-inflammatory effect on the adipose tissue of HFD-fed mice, which may eventually lead to the primary prevention of chronic inflammation-related diseases.

Information

Type
Full Papers
Copyright
Copyright © The Authors 2014 
Figure 0

Table 1 Primers used for real-time PCR analysis

Figure 1

Table 2 Body weight (BW), tissue weight and plasma parameters of normal chow (NC)-fed mice, high-fat diet (HFD)-fed mice and HFD+valine-proline-proline (VPP)-fed mice for a test period of 10 weeks (Mean values with their standard errors, n 7)

Figure 2

Fig. 1 Dietary fat and valine-proline-proline (VPP) modulates the expression levels of specific integrins on the surface of mouse peripheral blood monocytes. Flow cytometric analysis was used to assess the abundance of individual integrin species on the cell surface of monocytes from the peripheral blood of normal chow (NC)-fed mice (□), high-fat diet (HFD)-fed mice () and HFD+VPP-fed mice (). Each group was treated for a test period of 10 weeks (n 5–8 animals per group), and specific integrins were identified using cognate monoclonal antibodies as described in the Materials and methods section. Values are means, with their standard errors represented by vertical bars. * Mean value was significantly different from that of the HFD group (P< 0·05). MFI, mean fluorescence intensity.

Figure 3

Fig. 2 Valine-proline-proline (VPP) attenuates high-fat diet (HFD)-induced macrophage infiltration into adipose tissue. After a test period of 10 weeks, stromal vascular fractions were isolated from the epididymal visceral adipose tissue of the different treatment groups (normal chow (NC)-fed mice (□), high-fat diet (HFD)-fed mice () and HFD+VPP-fed mice ()), and the relative amounts of activated monocytes (CD11b+/CD11c+ cells), M1 macrophages (F4/80+/CD11c+ cells) and M2 macrophages (F4/80+/CD204+ cells) were determined by flow cytometric analysis. Values are means (n 6–7 animals per group), with their standard errors represented by vertical bars. Mean value was significantly different from that of the HFD group: * P< 0·05, ** P< 0·01, *** P< 0·001.

Figure 4

Fig. 3 Valine-proline-proline (VPP) reduces adipose tissue inflammation and macrophage accumulation in the adipose tissue of high-fat diet (HFD)-fed mice. The formation of crown-like structures (CLS) in the epididymal adipose tissue of HFD-fed and HFD+VPP-fed mice for a test period of 10 weeks was analysed. (a) Histology of the epididymal adipose tissue of HFD-fed and HFD+VPP-fed mice. Epididymal fat tissue was stained with the anti-F4/80 antibody. The arrows indicate the CLS. (b) Quantification of the number of CLS in HFD-fed and HFD+VPP-fed mice. The number of CLS was counted as described in the Materials and methods section. Values are means (n 7 animals per group), with their standard errors represented by vertical bars. * Mean value was significantly different from that of the HFD group (P< 0·05). A colour version of this figure can be found online at http://www.journals.cambridge.org/bjn

Figure 5

Fig. 4 Valine-proline-proline (VPP) suppresses the expression of pro-inflammatory cytokines and the chemokine receptor in adipose tissue. mRNA expression of inflammatory markers in epididymal adipose tissue from mice fed with normal chow (NC; □), a high-fat diet (HFD; ) and a HFD+VPP () for a test period of 10 weeks. Values are means (n 5 animals per group), with their standard errors represented by vertical bars. Mean value was significantly different from that of the HFD group: * P< 0·05, ** P< 0·01. MCP-1, monocyte chemoattractant protein-1; CCR2, CC chemokine receptor 2.